Weight Watchers Q4 rev $163M, net loss $6M; clinical subs up 42%; FY2026 rev guidance $620-635M

WW INTERNATIONAL, INC.

Q4 total revenue $163M (-12% YoY); net loss $6M vs income $25M YoY; adjusted EBITDA $18M (11.1% margin).
End of period subscribers 2.8M (-17%); clinical subs 130K (+42%); clinical sub revenue $27M (+32%).
FY2025 revenue and Adjusted EBITDA exceeded previously provided guidance.
FY2026 guidance: revenue $620-635M, Adjusted EBITDA $105-115M. Q1 subs ~2.65M total, ~200K clinical.
Company cites GLP-1 transformation; 2026 seen as inflection year for sustainable growth.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

WW INTERNATIONAL, INC. reported full year 2026 results: revenue $620 million to $635 million. Guidance initiated.

Period: full year 2026
Revenue: $620 million to $635 million
Guidance: initiated
Result: guidance update

Exact text from the filing

Revenue guidance of $620 million to $635 million.

View on SEC.gov

Browse all earnings releases →

WW INTERNATIONAL, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-107148

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.